ClinicalTrials.govpublic full text
Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease
alzheimer's disease, placebo controlled, randomised, histamine, h3 antagonist, double blind, cognition, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 876511
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.